 SOUTH SAN FRANCISCO, Calif., May 03, 2022 GLOBE NEWSWIRE -- DICE Therapeutics, Inc. Nasdaq: DICE, a biopharmaceutical company leveraging its proprietary technology platform to build a pipeline of novel oral therapeutic candidates to treat chronic diseases in immunology and other therapeutic areas, today announced that management will present at the Bank of America Securities 2022 Healthcare Conference on Wednesday, May 11, 2022 at 1:20 p.m. PT 4:20 p.m. ET. 